Judge Finds Purdue's OxyContin Patents Enforceable

Law360, New York (January 8, 2008, 12:00 AM EST) -- A New York federal judge has found that Purdue Pharma LP did not engage in conduct that invalidated its patents for OxyContin in a ruling that the drug company claims severely damages antitrust claims against it in consolidated litigation.

U.S. District Judge Sidney H. Stein of the Southern District of New York ruled on Monday that drug companies Mallinckrodt Inc., KV Pharmaceutical Co. and Actavis Totowa LLC failed to show “by clear and convincing evidence” that Purdue engaged in inequitable conduct in prosecuting the OxyContin patents...
To view the full article, register now.